60
Participants
Start Date
February 28, 2023
Primary Completion Date
February 20, 2026
Study Completion Date
June 20, 2026
Mesalamine
Mesalamine (also known as mesalamine or 5- amino salicylic acid, 5-ASA) has a well-established role in UC management. It is the first line therapy for mild to moderate UC and it is considered the cornerstone in the management of UC
Fenofibrate 160mg
Fibrates, which are specific pharmacological agonists of PPARα, have been widely used in the treatment of hypercholesterolemia and hypertriglyceridemia.
RECRUITING
Tanta Unuversity, Tanta
Hend El-Said Abo Mansour, Faculty of Pharmacy, Menoufia University
UNKNOWN
Monir Hussein Bahgat, Faculty of Medicine, Mansura University
UNKNOWN
Tanta University
OTHER